For the purpose of discovering novel type-II inhibitors of vascular endothelial growth factor receptor 2 (VEGFR2) kinase, we designed and synthesized 5, 6-fused heterocyclic compounds bearing a anilide group. A co-crystal structure analysis of imidazo [1, 2-b] pyridazine derivative 2 with VEGFR2 revealed that the N1-nitrogen of imidazo [1, 2-b] pyridazine core interacts with the backbone NH group of Cys919. To retain this essential ...